Search clinical trials for: DPP-4 inhibitor (sitagliptin)
Total 2691 results
-
Brigham and Women's HospitalCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 DiabetesUnited States
-
Brigham and Women's HospitalCompleted
-
University of PadovaCompletedType 2 DiabetesItaly
-
Brigham and Women's HospitalCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital with Nanjing Medical University; Beijing Hospital and other collaboratorsCompletedDiabetes Mellitus, Type 1China
-
George Medicines PTY LimitedThe George Institute; Brandon BiocatalystNot yet recruitingType 2 Diabetes
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimCompleted
-
Mackay Memorial HospitalUnknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Vivasure Medical LimitedCompletedPercutaneous CFA Arteriotomy ClosureIreland, Germany
-
Weill Medical College of Cornell UniversityPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
Nanjing Medical UniversityUnknown
-
Second Affiliated Hospital of Soochow UniversityUnknown
-
Brigham and Women's HospitalCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Beijing Chao Yang HospitalRecruiting
-
National Institute on Aging (NIA)Completed
-
Istituto Clinico HumanitasRecruitingColorectal Cancer | SurgeryItaly
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
Eurofarma Laboratorios S.A.CompletedDiabetes Mellitus, Type 2Brazil
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Non-Insulin-Dependent
-
Samsung Medical CenterJW PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
University of VermontMerck Sharp & Dohme LLCUnknown
-
University of Colorado, DenverMerck Sharp & Dohme LLCCompletedCardiovascular Disease | Type 2 DiabetesUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Merck Sharp & Dohme LLCCompleted
-
University of PisaMerck Sharp & Dohme LLCCompleted
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownType 2 Diabetes MellitusChina
-
Hoffmann-La RocheCompletedRheumatoid ArthritisGermany, Poland, United States, Australia, Brazil, Canada, Estonia, Greece, Ireland, Mexico, New Zealand, South Africa, Spain, United Kingdom
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompleted
-
NeuroBo Pharmaceuticals Inc.RecruitingNON-ALCOHOLIC STEATOHEPATITISUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Serbia, South Africa, Taiwan, Romania, Algeria, Hong Kong, Brazil, China, Czechia
-
University at BuffaloWithdrawn
-
Asha NayakMerck Sharp & Dohme LLC; Gilead SciencesTerminatedRecurrence | Non Small Cell Lung Cancer | MetastasisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Chronic Renal Insufficiency
-
Novartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus